Oxford Covishield Vaccine
- All
- News
- Videos
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
No Ban On Covishield, Request Must For Approval Process: EU Envoy To India
European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.
-
"Hope To Resolve Soon": Adar Poonawalla On Covishield, EU Travel Issues
Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the India-made version of the AstraZeneca vaccine
-
How to Download COVID-19 Vaccine Certificate
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
Won't Affect India: Serum Wants Nod For 50 Lakh Covishield Doses To UK
The world's largest vaccine manufacturer by volume, Serum Institute of India, has sought permission from the Centre to supply 50 lakh doses of Oxford COVID-19 vaccine Covishield to the United Kingdom, citing an agreement with AstraZeneca in this regard.
-
"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield
Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.
-
Sri Lanka May Not Use China Vaccine, Orders 13.5 Million Doses From India
Sri Lanka has ordered 13.5 million Oxford AstraZeneca coronavirus vaccines in addition to the 500,000 doses gifted by India, and the country may not use Chinese vaccines in the second phase of immunisation, a government spokesman said today.
-
"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines
World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.
-
A Look Inside World's Biggest Vaccine Factory, Serum Institute Of India
The tiny clinking vials supervised by silent PPE-wearing technicians belie the excitement inside the world's largest vaccine manufacturer, the Serum Institute of India, a major player in the fight against coronavirus.
-
Coronavirus Vaccination: Centre To Compare Covaxin, Covishield Vaccines On Different Parameters
The Ministry of Health and Family Welfare (MoHFW) said on Thursday that the government will compare the coronavirus vaccines - Covishield and Covaxin on different parameters for the purposes of recordkeeping.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
Indian Medical Experts Support Call For Covishield Vaccine Safety Review
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of the Oxford/AstraZeneca's COVID-19 vaccine, administered in India as Covishield.
-
Lancet Study On Covishield Vaccine Protection Decline Is Misquoted: Experts
The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
-
Next Virus Could Be More Lethal, Warns Oxford University Covid Vaccine Creator
The scientist behind the creation of the Oxford/AstraZeneca vaccine, administered in India as Covishield to protect against COVID-19, on Monday warned that the next virus to hit humankind may be even more lethal and contagious.
-
No Ban On Covishield, Request Must For Approval Process: EU Envoy To India
European Union (EU) Ambassador to India Ugo Astuto has clarified there is no ban in the EU on the Covishield vaccine produced by the Serum Institute of India (SII) and developed by AstraZeneca and Oxford University.
-
"Hope To Resolve Soon": Adar Poonawalla On Covishield, EU Travel Issues
Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the India-made version of the AstraZeneca vaccine
-
How to Download COVID-19 Vaccine Certificate
There are two COVID-19 vaccines currently in use in India. Covaxin is made by Bharat Biotech and Covishield is made by AstraZeneca/ Oxford and manufactured by the Serum Institute of India. Here’s how to download the COVID-19 vaccination certificate after both the shots have been administered.
-
Covishield Comprises Over 90% Of 12.76 Crore Covid Vaccines Given So Far: Government Data
Covishield, from the Oxford/AstraZeneca stable, comprises over 90 per cent of the 12.76 crore COVID-19 vaccines administered across the country so far, according to government data on Wednesday.
-
Won't Affect India: Serum Wants Nod For 50 Lakh Covishield Doses To UK
The world's largest vaccine manufacturer by volume, Serum Institute of India, has sought permission from the Centre to supply 50 lakh doses of Oxford COVID-19 vaccine Covishield to the United Kingdom, citing an agreement with AstraZeneca in this regard.
-
"Proud To Take The Jab": What Natasha Poonawalla Said On Serum Institute's Covishield
Natasha Poonawalla, Serum Institute of India's Executive Director, was today vaccinated against COVID-19. She received the first shot of Covishield which is manufactured by her company and developed by AstraZeneca and Oxford University.
-
Sri Lanka May Not Use China Vaccine, Orders 13.5 Million Doses From India
Sri Lanka has ordered 13.5 million Oxford AstraZeneca coronavirus vaccines in addition to the 500,000 doses gifted by India, and the country may not use Chinese vaccines in the second phase of immunisation, a government spokesman said today.
-
"Please Be Patient": Adar Poonawalla To Nations Waiting For Vaccines
World's biggest vaccine maker Serum Institute of India's Adar Poonawalla this morning urged the nations to "be patient" amid the wait for Covishield, the coronavirus vaccine that the SII has developed in partnership with the Oxford University and British-Swedish pharma firm AstraZeneca.
-
A Look Inside World's Biggest Vaccine Factory, Serum Institute Of India
The tiny clinking vials supervised by silent PPE-wearing technicians belie the excitement inside the world's largest vaccine manufacturer, the Serum Institute of India, a major player in the fight against coronavirus.
-
Coronavirus Vaccination: Centre To Compare Covaxin, Covishield Vaccines On Different Parameters
The Ministry of Health and Family Welfare (MoHFW) said on Thursday that the government will compare the coronavirus vaccines - Covishield and Covaxin on different parameters for the purposes of recordkeeping.
